Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
27 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jw-therapeutics-announces-nmpa-approval-of-the-supplemental-biological-license-application-for-carteyva-in-adult-patients-with-relapsed-or-refractory-mantle-cell-lymphoma-302231445.html
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/preliminary-clinical-data-on-relma-cel-injection-in-adults-with-active-systemic-lupus-erythematosus-in-china-at-the-eular-2024-congress-302159238.html
10 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jw-therapeutics-announces-ind-approval-for-the-clinical-trial-of-relma-cel-in-patients-with-moderately-or-severely-refractory-systemic-lupus-erythematosus-301793059.html
29 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jw-therapeutics-announces-its-cell-immunotherapy-drugs-have-successfully-benefited-406-patients-301784761.html
08 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jw-therapeutics-announces-initiation-of-clinical-study-of-carteyva-in-first-line-treatment-in-patients-with-high-risk-large-b-cell-lymphoma-301763117.html
28 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jw-therapeutics-announces-initiation-of-clinical-study-of-jwatm214-in-patients-with-advanced-hepatocellular-carcinoma-301752957.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?